新关注 > 信息聚合 > 亚宝药业中期业绩预增45%-55%

亚宝药业中期业绩预增45%-55%

Yabao pharmaceutical intermediate forecasted 45%-55%

2015-07-07 21:29:56来源: 东方财富网

亚宝药业(600351)7月7日晚间发布2015 年半年度业绩预增公告,公司预计上半年归属于母公司所有者的净利润将比上年同期增长 45%-55%。上年同期实现归属于母公司所有者的净利润为9321.3...

Yabao pharmaceutical 7 evening (600351) July release 2015 semi annual yejiyuzeng notice, the company expects half belonging to the owner of the parent company net profit will over the previous year growth in the same period of 45% - 55%. Net profit attributable to the parent company's owner was 9321.3 in the same period last year...